Institute of Musculoskeletal Health and Arthritis (IMHA)
In partnership with
Institute of Neurosciences, Mental Health and Addiction (INMHA)
AstraZeneca Canada Inc. (Az)
| Important Dates | |
| Opportunity Launched | June 2006 |
| Content Last Updated | July 7, 2006 (Review Process and Evaluation Criteria) |
| November 1, 2006 | Registration Deadline - Registration packages must be courier stamped by this date. |
| February 1, 2007 | Full applications must be courier stamped by this date. |
| June 30, 2007 | Anticipated notification of decision. |
| June 30, 2007 | Anticipated start date. |
| Funds Available | |
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
| |
| Summary | |
| The purpose of the Community Alliances for Health Research and Knowledge Exchange on Pain initiative is to engage active partnerships between research teams and community organizations which will foster high quality research and knowledge translation and exchange in research on Pain. | |
The purpose of the Community Alliances for Health Research and Knowledge Exchange on Pain initiative is to engage active partnerships between research teams and community organizations which will foster high quality research and knowledge translation and exchange on pain.
Knowledge Translation and Exchange (KTE) is an integral component of IMHA's strategic plan KTE at CIHR is defined as the exchange, synthesis and ethically sound application of research findings within a complex set of interactions among researchers and knowledge users - to accelerate the capture of the benefits of research for Canadians through improved health, more effective services and products, and a strengthened health care system.
Community Alliances are based on equal and active partnerships between a community organization(s) and research team(s) whose members are affiliated with local universities, hospitals or other institutions capable of conducting health research. The partner may also contribute funding or in-kind support to the research project (such as office space or staff time), according to its ability to do so. Community partners include health-oriented service clubs, community foundations and organizations, local, provincial and national health charities, hospital and research institute foundations, municipal and regional health authorities, district health councils, provincial government agencies and private sector organizations.
Funding through this program allows research teams to conduct research in knowledge translation and exchange on pain related to community health and health care issues, as identified and supported by the partner(s). The important distinction between a formal Community Alliance and other forms of partnership between the proposed CIHR and other health research funders is that the partner is a joint participant with the research team in all aspects of the research project. There is no pre-determined definition of joint participation; it may take many forms, depending on the needs and capabilities of the organizations. The guiding principle is that groups from the community be active and ongoing participants in research, training and knowledge translation and exchange activities, and that their roles have been agreed upon in a spirit of equity and mutual benefit. It is expected that a Community Alliance for health research and knowledge exchange on pain will be structured to ensure the active involvement of organizations from the community in the overall research program.
Generally, it is expected that partners will contribute to:
Community organizations may also spearhead some of these activities. In some cases, they will be involved in conducting the research.
An effective plan for knowledge translation and exchange to those agencies, organizations and individuals who can implement this plan into improvements in health and health care as it relates to pain for members of the community is a key component of this initiative. As in all health research funded by CIHR, investigators are also expected to communicate their findings to the international research community through the appropriate medium for rigorously evaluated publication, with provision for the protection of intellectual property, where appropriate. While the research program funded through the Community Alliances for Health Research and Knowledge Exchange on Pain initiative originates in the interest of a community, the anticipated outcome should be of more general applicability.
The CIHR-IMHA is dedicated to identifying and developing collaborations with other CIHR institute(s), branch(es) or office(s), funding organizations and stakeholders to enhance the availability of funding for this strategic initiative, and to create, where appropriate, opportunities for knowledge exchange and translation related to the scope of this particular initiative. Applicants are invited to visit the Descriptions of Partners to find a list of partners and their respective mandates and/or strategic interests. This list will continue to evolve as new partners join in this initiative. The specific research foci and requirements for each partner are outlined in the section "Objectives".
The specific objectives of this initiative are:
Relevant Research Areas:
The Institute of Musculoskeletal Health and Arthritis encourages researchers across disciplines within the Arthritis, Bone, Skin, Muscle, Oral Health and/or MSK Rehabilitation Research communities, and across all four of CIHR research pillars to develop research in pain.
The CIHR -IMHA and partners will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described above.
Prior to peer review, the CIHR-IMHA and partners will have access to anonymized project titles and summaries to conduct relevance review.
The following criteria will be used in conducting the relevance review.
Upon completion of peer review, the CIHR-IMHA and partners will receive the ranking list, merit scores (ratings) and recommendations on funding level and award term for the applications that fall in the fundable range and have been determined to be relevant to the specific research areas and objectives of the initiative. The list will be used for funding decision-making purposes and will remain anonymous.
The review of applications for relevance to the strategic initiative will have no impact on the peer review process.
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Randomized Controlled Trials (RCTs) will not be considered under this RFA.
Specific Eligibility Requirements
Eligibility requirements specific to this Request for Applications include the following:
Applicants should review the Tri-Agency (CIHR, NSERC and SSHRC) financial administration guidelines Use of Grant Funds for a complete listing and description of allowable costs and activities.
A CIHR peer review committee will evaluate the full applications. The committee may be drawn from one of CIHR's pre-existing committees or may be created specifically for this Request for Applications. Committee members are selected based on suggestions from many sources including the institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see Peer Review.
Peer review will be conducted in accordance with The CIHR Peer Review Process: Policies and Responsibilities of Grants Committee Members, including the standard evaluation criteria described under "Factors for Assessment" (section 6.2).
In addition, the following evaluation criteria specific to this Request for Applications will apply. CIHR recognizes that applications will emphasize different approaches to research and to knowledge translation, therefore reviewers and committees are expected to weight criteria such as these differently from one application to another.
Knowledge Translation and Exchange (KTE) is an integral component of IMHA's strategic plan. (Updated: 2006-07-07)
KTE is defined as the exchange, synthesis and ethically sound application of research findings within a complex set of interactions among researchers and knowledge users - to accelerate the capture of the benefits of research for Canadians through improved health, more effective services and products, and a strengthened health care system.
The Knowledge Translation and Exchange (KTE) plan is a mandatory component of this program. As such the KTE plan will consist of 50% of the peer review rating. The KTE plan should be included in the description of the research. Since the KTE plan is mandatory for this application, please ignore the optional funds component described on the KTE module. For further info, please refer to the KTE module.
This Request for Applications will follow the General Guidelines for Grant Programs. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Request for Applications. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this Request for Applications and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Request for Applications will be collected, used and disclosed in compliance with the PIPEDA.
Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes / partners will be identified on the Authorization for Funding and decision letter.
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
The application process is comprised of two steps: Registration and Full Application.
Review the application instructions provided in How to Apply for Funding.
Select "Operating Grants" (Registration and Application) from the Grant Programs Application Packages.
Additional instructions must be followed for this RFA:
Send the completed registration and application packages by courier to:
RE: "Community Alliances in Health Research and Knowledge Exchange on Pain"
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Tamara Marshall
Program Delivery Officer
Canadian Institutes of Health Research
Telephone: (613) 941-0861
Fax: (613) 954-1800
Email: tmarshall@cihr-irsc.gc.ca
For questions about this initiative and research objectives contact:
Sophia Tsouros
Project Manager / Analyst
CIHR - Institute of Musculoskeletal Health and Arthritis
Telephone: 613)954-3469
Fax: (613)954-1800
Email: stsouros@cihr-irsc.gc.ca
Note: Additional partners, including partners from industry and the private sector are expected to join this funding initiative over the coming year.
CIHR - Institute of Musculoskeletal Health and Arthritis
The goal of the CIHR - Institute of Musculoskeletal Health and Arthritis is to support research to sustain health and enhance quality of life by eradicating the pain, suffering and disability caused by arthritis, musculoskeletal, oral and skin conditions.
CIHR - Institute of Neurosciences, Mental Health and Addiction
The vision of the Institute of Neurosciences, Mental Health and Addiction (INMHA) is that innovative research will provide new knowledge of the biological and socio-cultural processes underlying neurological, mental and addictive disorders. As such, the INMHA's mission is to foster excellence in innovative, ethically responsible research in Canada that aims to increase our knowledge of the functioning and disorders of the brain and the mind, the spinal cord, the sensory and motor systems, as well as mental health, mental illness and all forms of addiction. The INMHA intends to support initiatives that mobilize and link scientists in innovative collaborative programs across these research domains. The INMHA seeks to translate this new knowledge into a better quality of life for all Canadians through improved outcomes, health promotion and health care services.
Partners
AstraZeneca Canada Inc. (AZ)
AstraZeneca is an international pharmaceutical company with a strong research base and product portfolio designed to fight disease in seven areas of medical need including the central nervous system (CNS). The company's CNS research portfolio is focused on the areas of chronic pain management and both neurologic and psychiatric disease.
